These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26981497)

  • 1. Comparison Between Tadalafil Plus Paroxetine and Paroxetine Alone in the Treatment of Premature Ejaculation.
    Moudi E; Kasaeeyan AA
    Nephrourol Mon; 2016 Jan; 8(1):e32286. PubMed ID: 26981497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective evaluation of the efficacy of daily paroxetine/tadalafil combination in patients with premature ejaculation and erectile dysfunction.
    Onal B; Can O; Ermec B; Culha MG
    Eur Rev Med Pharmacol Sci; 2023 May; 27(9):4248-4253. PubMed ID: 37203851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a tadalafil 5-mg single daily dose on lifelong premature ejaculation: A single-blinded placebo-controlled study.
    Abou Faddan AH; Gaber HD; Oamonov D
    Arab J Urol; 2022; 20(2):100-104. PubMed ID: 35530567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tadalafil and fluoxetine in premature ejaculation: prospective, randomized, double-blind, placebo-controlled study.
    Mattos RM; Marmo Lucon A; Srougi M
    Urol Int; 2008; 80(2):162-5. PubMed ID: 18362486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Dapoxetine /Tadalafil and Paroxetine/Tadalafil Combination Therapies for the Treatment of the Premature Ejaculation: A Randomized Clinical Trial.
    Mohseni Rad H; Zahirian Moghadam T; Hosseinkhani A; Nima Soluki N; Amani F
    Urol J; 2021 Nov; 19(2):138-143. PubMed ID: 34773634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with selective serotonin reuptake inhibitors and phosphodiesterase-5 inhibitors in the treatment of premature ejaculation.
    Polat EC; Ozbek E; Otunctemur A; Ozcan L; Simsek A
    Andrologia; 2015 Jun; 47(5):487-92. PubMed ID: 24811578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation.
    Salonia A; Maga T; Colombo R; Scattoni V; Briganti A; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    J Urol; 2002 Dec; 168(6):2486-9. PubMed ID: 12441946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized single-center study to compare the efficacy and tolerability of tadalafil once daily plus lidocaine anesthetic spray on premature ejaculation.
    Dell'Atti L; Galosi AB; Ippolito C
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):1036-1040. PubMed ID: 28338191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On-demand use of tramadol, sildenafil, paroxetine and local anaesthetics for the management of premature ejaculation: A randomised placebo-controlled clinical trial.
    Gameel TA; Tawfik AM; Abou-Farha MO; Bastawisy MG; El-Bendary MA; El-Gamasy Ael-N
    Arab J Urol; 2013 Dec; 11(4):392-7. PubMed ID: 26558110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of premature ejaculation with paroxetine hydrochloride.
    McMahon CG; Touma K
    Int J Impot Res; 1999 Oct; 11(5):241-245; discussion 246. PubMed ID: 10553802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and long-term follow-up results of daily 5-mg tadalafil as a treatment for erectile dysfunction and premature ejaculation.
    Mohamed Gharib T; Abdel-Al I; Elatreisy A; Kandeel W; El-Shaer W; Abdrabuh AM; Mohamed Salih E; Sebaey A
    Arab J Urol; 2022; 20(1):49-53. PubMed ID: 35223110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine, dual serotonin and norepinephrine reuptake inhibitor, versus paroxetine, selective serotonin reuptake inhibitor, in the treatment for premature ejaculation.
    Ozcan L; Polat EC; Otunctemur A; Ozbek E
    Int Urol Nephrol; 2015 Feb; 47(2):283-7. PubMed ID: 25557853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of paroxetine on-demand in premature ejaculation].
    Rivera P; González R; González F; Storme O
    Actas Urol Esp; 2005 Apr; 29(4):387-91. PubMed ID: 15981427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Changes in Serum 5-Hydroxy-Tryptamine Concentrations and Improvement in Clinical Symptoms in Primary Premature Ejaculation with Paroxetine Treatment.
    Guo Y; Wang Y; Wang X; Ye G; Jiang Y; Xiong W
    Med Sci Monit; 2015 Aug; 21():2521-7. PubMed ID: 26305631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonresponders to daily paroxetine and another SSRI in men with lifelong premature ejaculation: a pharmacokinetic dose-escalation study for a rare phenomenon.
    Janssen PK; Touw D; Schweitzer DH; Waldinger MD
    Korean J Urol; 2014 Sep; 55(9):599-607. PubMed ID: 25237462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of epelsiban in the treatment of men with premature ejaculation: a randomized, double-blind, placebo-controlled, fixed-dose study.
    Shinghal R; Barnes A; Mahar KM; Stier B; Giancaterino L; Condreay LD; Black L; McCallum SW
    J Sex Med; 2013 Oct; 10(10):2506-17. PubMed ID: 23937679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and combined dapoxetine with sildenafil in treatment of patients with premature ejaculation: A randomised placebo-controlled clinical trial.
    Abu El-Hamd M; Abdelhamed A
    Andrologia; 2018 Feb; 50(1):. PubMed ID: 28497478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premature ejaculation: bother and intravaginal ejaculatory latency time in Iran.
    Zargooshi J
    J Sex Med; 2009 Dec; 6(12):3478-89. PubMed ID: 19732308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The network meta-analysis of "on-demand" and "daily" use of paroxetine in treating men with premature ejaculation from randomized controlled trials.
    Zhou Z; Yang Z; Cui Y; Zhang X; Wang Y; Zhang Y
    Andrologia; 2022 Jun; 54(5):e14388. PubMed ID: 35122448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of three phosphodiesterase type 5 inhibitors on ejaculation latency time in lifelong premature ejaculators: a double-blind laboratory setting study.
    Gökçe A; Halis F; Demirtas A; Ekmekcioglu O
    BJU Int; 2011 Apr; 107(8):1274-7. PubMed ID: 21929518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.